rhodamine 123 has been researched along with quinoxalines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacon, JA; Cramer, CT; Holmuhamedov, E; Meglasson, MD; Petrella, DK; Sun, EL; Ulrich, RG | 1 |
| Chen, MH; Cheng, YN; Li, X; Qu, XJ; Sun, LR; Tang, W; Ward, SG; Yuan, HY | 1 |
2 other study(ies) available for rhodamine 123 and quinoxalines
| Article | Year |
|---|---|
Disruption of mitochondrial activities in rabbit and human hepatocytes by a quinoxalinone anxiolytic and its carboxylic acid metabolite.
Topics: Adolescent; Adult; Animals; Anti-Anxiety Agents; Cell Respiration; Cells, Cultured; Child, Preschool; Cyclopropanes; Female; Fluorescent Dyes; Humans; Liver; Male; Middle Aged; Mitochondria, Liver; Oxadiazoles; Oxidation-Reduction; Quinoxalines; Rabbits; Rats; Rhodamine 123; Species Specificity | 1998 |
Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Dyes; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia, Myeloid; Quinoxalines; Rhodamine 123 | 2009 |